Pharma BD Deal Intelligence

Alexion Pharmaceuticals Inc. / Synageva BioPharma

2015 · Acquisition/Merger · $8.4B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

36

Underwhelmed — fell short of the thesis.

Alexion acquired Synageva BioPharma for $8.4B for Kanuma (sebelipase alfa).

Key facts

Announced May 06, 2015
Closed Jun 19, 2015
Deal value $8.4B
Deal type Acquisition/Merger
Therapeutic area Rare Disease
Key assets Kanuma

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals